製藥和生物技術製造與供應貿易：2020-2025

《製藥和生物技術領域的製造和供應交易》提供了對公司如何以及為何達成製造和供應交易的深入了解和分析。這份經過全面修訂和更新的報告提供了 2019 年至 2025 年的詳細製造和供應交易。

此報告提供雙方宣布的製造和供應交易的付款條款。這些數據為付款條款和其他貿易條款提供了有用的見解。

了解潛在合作夥伴談判交易條款的彈性可以為談判過程提供重要的見解，讓您了解談判條款時會發生什麼。許多中小企業可能會要求詳細的付款條款，但細節決定成敗，例如如何發起付款以及如何轉讓權利。

本報告提供了當前協議交易和合作夥伴關係資料庫中記錄的自 2020 年以來宣布的製造和供應交易的綜合列表，包括可用的財務條款，以及公司及其合作夥伴向美國證券交易委員會提交的實際製造和供應交易文件的在線副本鏈接。

報告的第一章介紹了製造和供應交易和商業活動。

第 1 章對報告進行了介紹，第 2 章概述並分析了製造和供應趨勢，並討論了各種貿易類型的優點。

第 3 章概述了製造和供應交易的結構。

第 4 章回顧了 2020 年及以後的主要製造和供應機會。交易按價值列出。對於已向美國證券交易委員會公開披露協議的案件，您可以透過這些連結透過目前協議交易和聯盟資料庫在線存取這些協議。

第 5 章提供了最活躍的 25 家製造和供應貿易公司的綜合清單。每個交易標題都透過當前協議的交易和聯盟資料庫連結到完整交易記錄的線上版本，並在可用時連結到實際合約文件，從而可以輕鬆按需存取每個交易記錄。

第 6 章全面詳細地回顧了自 2020 年以來達成或宣布的製造和供應交易，其中提供了合約文件，按公司 A-Z、治療領域、技術和行業垂直順序排列。合約文件詳細介紹了雙方就製造和供應交易達成的實際條款和條件。

交易目錄包含自 2019 年以來宣布的所有製造和供應交易的綜合清單。每個清單都按公司 A-Z、治療領域和技術類型組織為貿易目錄。每個交易標題都透過超連結連結到交易記錄的線上版本，包括實際的合約文件（如果有）。

該報告還包含大量圖表和圖形，重點介紹 2020 年及以後的製造和供應交易趨勢和活動。

目錄

摘要整理

第1章 簡介

第2章 製造業和供應鏈趨勢

• 簡介
• 製造·供給交易定義
• 2020年以後的製造·供給交易趨勢
  • 製造·供給交易的各年度轉變，2020年～2025年
  • 各開發階段的製造·供給交易，2020年～2025年
  • 各產業部門的製造·供給交易，2020年～2025年
  • 各治療領域的製造·供給交易，2020年～2025年
  • 各技術類型的製造·供給交易，2020年～2025年
  • 最活躍的各企業製造·供給交易，2020年～2025年
• 為什麼要簽訂製造和供應合作協議？
• 製造與供應鏈交易的未來

第3章 製造·供給交易結構概要

• 簡介
• 製造及供給交易結構

第4章 主要製造·供給交易

• 簡介
• 各金額首位製造·供給交易

第5章 最活躍的製造·供給交易廠商前幾名25公司

• 簡介
• 最活躍的製造·供給交易廠商前幾名25公司

第6章 含契約名錄的製造·供給交易

• 簡介
• 按2020年～2025年的交易的製造·供給交易
• 交易名錄
• 行業名錄 - 製造和供應行業（按公司劃分）(AZ)
• 貿易目錄 - 按治療領域劃分的製造和供應交易
• 行業名錄 - 按技術類型劃分的製造和供應行業
• 關於調查公司
• 目前聯盟
• 目前契約
• Current 來自Partnering的最近的報告標題

Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology provides a detailed understanding and analysis of how and why companies enter manufacturing and supply deals.

Fully revised and updated, the report provides details of manufacturing and supply deals from 2019 to 2025.

The report provides access to manufacturing and supply deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred - contract documents provide this insight where press releases and databases do not.

This report contains a comprehensive listing of manufacturing and supply deals announced since 2020 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual manufacturing and supply contract documents as submitted to the Securities Exchange Commission by companies and their partners.

The initial chapters of this report provide an orientation of manufacturing and supply dealmaking and business activities.

Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview and analysis of the trends in manufacturing and supply as well as a discussion on the merits of the type of deal.

Chapter 3 provides an overview of the structure of manufacturing and supply deals.

Chapter 4 provides a review of the leading manufacturing and supply deals since 2020. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.

Chapter 5 provides a comprehensive listing of the top 25 most active manufacturing and supply dealmaker companies. Each deal title links via Current Agreements deals and alliances database to an online version of the full deal record, and where available, the actual contract document, providing easy access to each deal record on demand.

Chapter 6 provides a comprehensive and detailed review of manufacturing and supply deals organized by company A-Z, therapy, technology and industry type signed and announced since 2020 where a contract document is available. Contract documents provide an indepth insight into the actual deal terms agreed between the parties with respect to the manufacturing and supply deal.

The deal directory includes a comprehensive listing of all manufacturing and supply deals announced since 2019. Each listing is organized as a deal directory by company A-Z, therapeutic area and technology type. Each deal title links via hyperlink to an online version of the deal record including, where available, the actual contract document.

The report also includes numerous table and figures that illustrate the trends and activities in manufacturing and supply dealmaking since 2020.

In conclusion, this report provides everything a prospective dealmaker needs to know about manufacturing and supply alliances.

Key benefits

Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology provides the reader with the following key benefits:

• Understand deal trends since 2020
• Browse manufacturing and supply deals
• Benchmark analysis - identify market value of transactions
• Financials terms
• Directory of deals by company A-Z, therapy focus and technology type
• Leading deals by value
• Most active dealmakers
• Identify assets and deal terms for each transaction
• Access contract documents - insights into deal structures
• Due diligence - assess suitability of your proposed deal terms for partner companies
• Save hundreds of hours of research time

Report scope

• Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology is intended to provide the reader with an in-depth understanding of the manufacturing and supply trends and structure of deals entered into by leading biopharma companies worldwide.

Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology includes:

• Trends in manufacturing and supply dealmaking in the biopharma industry
• Overview of manufacturing and supply deal structure
• Directory of manufacturing and supply deal records covering pharmaceutical and biotechnology
• The leading manufacturing and supply deals by value
• Most active manufacturing and supply dealmakers
• The leading manufacturing and supply partnering resources

In Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology, the available deals are listed by:

• Company A-Z
• Headline value
• Therapeutic area
• Technology type
• Each deal title links via Weblink to an online version of the actual deal record, providing easy access to each contract document where available.
• Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology provides comprehensive access to available records for manufacturing and supply deals, including contract documents where available.

Analyzing contract agreements allows due diligence of:

• What are the rights granted or optioned?
• What rights are granted by the agreement?
• What exclusivity is granted?
• What is the payment structure for the deal?
• How are sales and payments audited?
• What is the deal term?
• How are the key terms of the agreement defined?
• How are intellectual property rights handled and owned?
• Who is responsible for commercialization?
• Who is responsible for development, supply, and manufacture?
• How is confidentiality and publication managed?
• How are disputes resolved?
• Under what conditions can the deal be terminated?
• What happens when there is a change of ownership?
• What sublicensing and subcontracting provisions have been agreed?
• Which boilerplate clauses does the company insist upon?
• Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
• Which jurisdiction does the company insist upon for agreement law?

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in manufacturing and supply dealmaking

• 2.1. Introduction
• 2.2. Definition of manufacturing and supply deal
• 2.3. Trends in manufacturing and supply deals since 2020
  • 2.3.1. Manufacturing and supply dealmaking by year, 2020-2025
  • 2.3.2. manufacturing and supply dealmaking by phase of development, 2020-2025
  • 2.3.3. Manufacturing and supply dealmaking by industry sector, 2020-2025
  • 2.3.4. Manufacturing and supply dealmaking by therapy area, 2020-2025
  • 2.3.5. Manufacturing and supply dealmaking by technology type, 2020-2025
  • 2.3.6. Manufacturing and supply dealmaking by most active company, 2020-2025
• 2.4. Reasons for entering into manufacturing and supply partnering deals
• 2.5. The future of manufacturing and supply deals

Chapter 3 - Overview of manufacturing and supply deal structure

• 3.1. Introduction
• 3.2. manufacturing and supply agreement structure

Chapter 4 - Leading manufacturing and supply deals

• 4.1. Introduction
• 4.2. Top manufacturing and supply deals by value

Chapter 5 - Top 25 most active manufacturing and supply dealmakers

• 5.1. Introduction
• 5.2. Top 25 most active manufacturing and supply dealmakers

Chapter 6 - manufacturing and supply deals including contracts directory

• 6.1. Introduction
• 6.2. manufacturing and supply deals with contracts 2020-2025
• Deal directory
• Deal directory - manufacturing and supply dealmaking by companies A-Z
• Deal directory - manufacturing and supply dealmaking by therapy area
• Deal directory - manufacturing and supply dealmaking by technology type
• About Biopharma Research
• Current Partnering
• Current Agreements
• Recent report titles from Current Partnering

TABLE OF FIGURES

• Figure 1: Definition of manufacturing and supply
• Figure 2: Trends in manufacturing and supply deal announcements, 2020-2025
• Figure 3: Manufacturing and supply deals signed at each phase of development, 2020-2025
• Figure 4: Manufacturing and supply deals by industry sector, 2020-2025
• Figure 5: Manufacturing and supply deals by therapy area, 2020-2025
• Figure 6: Manufacturing and supply deals by technology type, 2020-2025
• Figure 7: Top 25 most active manufacturing and supply dealmakers, 2020-2025
• Figure 8: Top manufacturing and supply deals by value, 2020-2025
• Figure 9: Most active manufacturing and supply dealmakers, 2020-2025